Clinical Laboratory · Nov 1, 2026

Association between a C-Reactive Protein-Triglyceride Glucose Index and Chronic Kidney Disease in US Adults

By Xu J, Wang J

BACKGROUND: Chronic kidney disease (CKD) is a global health challenge. Inflammation and insulin resistance are established contributors to its pathogenesis. We sought to investigate the association between a novel C-reactive protein-triglyceride glucose index (CTI)), which integrates markers of inflammation and metabolic dysfunction, and the prevalence of CKD in a nationally representative sample. METHODS: This cross-sectional analysis included adults aged 20 years or older from the National Health and Nutrition Examination Survey (NHANES) cycles 1999 - 2004. A comprehensive review of the literature indicates that the diagnosis of chronic kidney disease (CKD) relies on meeting either of the following criteria: A reduced glomerular filtration rate (GFR), specifically an estimated GFR (eGFR) below 60 mL/minute/1.73 m²; the presence of albuminuria, defined as an albumin-to-creatinine ratio (ACR) exceeding 30 mg/g. The CTI was calculated using the formula: 0.412 x Ln (C-reactive protein) (mg/dL) + Ln [triglyceride (mg/dL) x fasting glucose (mg/dL)/2]. Logistic regression, curve fitting, and interaction effects were utilized to investigate the association between CTI and CKD. RESULTS: Among the 12,396 participants included, the prevalence of CKD was 11.0%. A strong positive dose-response relationship was observed between CTI and CKD prevalence. Logistic regression analysis revealed a positive association between CTI and CKD, even after adjusting for the confounding variables (odds ratio: (OR: 1.32, 95% CI: 1.25 - 1.38, p < 0.001). In addition, curve fitting after adjusting for all the confounding variables showed that there was a linear relationship between CTI and CKD (p for non-linearity = 0.254). CTI was positively correlated with CKD (p < 0.001). CONCLUSIONS: The novel C-reactive protein-triglyceride glucose index, a composite measure of inflammation and metabolic dysregulation, is strongly and independently associated with a higher prevalence of CKD among US adults. This index may serve as a valuable and simple tool for early identification of individuals at high risk for CKD in clinical and public health settings.

doi.org/10.7754/clin.lab.2025.251130PubMed 43038017Biomarkers

AgingResearch.News